Related Experiment Video
Updated: Sep 27, 2026

Development of an Insert Co-culture System of Two Cellular Types in the Absence of Cell-Cell Contact
Published on: July 17, 2016
Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast
M G Alexandrakis1, F H Passam, A Boula
1Department of Hematology, University Hospital of Heraklion, P.O. Box 1352 Heraklion, Crete, Greece. freda@med.uoc.gr
Abstract:
Angiogenesis plays an important role in multiple myeloma (MM) progression. Various mitogens such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) have been implicated in the angiogenic process of various malignancies. Interleukin-6 (IL-6) is a growth factor of myeloma cells and its signaling is mediated via a cell surface receptor complex (IL-6r). IL-6 and tumor necrosis factor-alpha (TNF-alpha) are involved in the secretion of VEGF by IL-6r expressing myeloma cells. In this study, serum FGF-2, VEGF, IL-6r, and TNF-alpha were measured in 46 untreated MM patients and were studied in relation to disease stage (by Salmon-Durie criteria) and severity [assessed by serum beta(2)-microglobulin (beta(2)M), C-reactive protein (CRP), alpha(1)-antitrypsin (alpha(1)AT), and lactic dehydrogenase (LDH) levels]. The results showed that FGF-2, VEGF, IL-6r, and TNF-alpha were significantly elevated in MM patients in comparison to controls ( p<0.008) and were significantly higher in stage III disease in comparison to stages I and II ( p<0.03). The mean concentrations of IL-6r were 877+/-374, 1220+/-308, 1431+/-878, and 453+/-180 pg/ml for stages I, II, and III and controls, respectively. Levels of beta(2)M, alpha(1)AT, CRP, and LDH were all significantly higher in MM patients than controls and increased with advancing stage of disease. There were positive correlations of both VEGF and FGF-2 with IL-6r, TNF-alpha, beta(2)M, alpha(1)AT, CRP, and LDH. We conclude that IL-6r and TNF-alpha increase in parallel to VEGF and FGF-2 with increasing stage of MM disease. These molecules correlate with biochemical markers of disease activity and may play a role in the progression of multiple myeloma.
Insights
Elevated levels of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (FGF-2), interleukin-6 receptor (IL-6r), and tumor necrosis factor-alpha (TNF-alpha) are linked to multiple myeloma (MM) progression. These factors correlate with disease stage and severity markers.
Area of Science:
- Oncology
- Immunology
- Biochemistry
Background:
- Angiogenesis is crucial for multiple myeloma (MM) progression.
- Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) are key mitogens in cancer.
- Interleukin-6 (IL-6) promotes myeloma cell growth, with signaling mediated by its receptor complex (IL-6r).
Purpose of the Study:
- To investigate the relationship between serum levels of FGF-2, VEGF, IL-6r, and TNF-alpha and the stage and severity of multiple myeloma.
- To assess the correlation of these angiogenic and inflammatory markers with established disease severity indicators.
Main Methods:
- Serum concentrations of FGF-2, VEGF, IL-6r, and TNF-alpha were measured in 46 untreated MM patients.
- Disease stage was determined using the Salmon-Durie criteria.
- Disease severity was assessed by serum beta(2)-microglobulin (beta(2)M), C-reactive protein (CRP), alpha(1)-antitrypsin (alpha(1)AT), and lactic dehydrogenase (LDH) levels.
Main Results:
- FGF-2, VEGF, IL-6r, and TNF-alpha were significantly elevated in MM patients compared to controls (p<0.008).
- These markers were significantly higher in stage III MM patients versus stages I and II (p<0.03).
- Positive correlations were observed between VEGF and FGF-2 with IL-6r, TNF-alpha, beta(2)M, alpha(1)AT, CRP, and LDH.
Conclusions:
- Serum IL-6r and TNF-alpha levels increase alongside VEGF and FGF-2 with advancing MM stage.
- These molecules correlate with biochemical markers of disease activity.
- IL-6r, TNF-alpha, VEGF, and FGF-2 may play significant roles in multiple myeloma progression.
More Related Videos
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Differentiation of Common Myeloid Progenitor Cells
Regulation of Hematopoietic Stem Cells
The Tumor Microenvironment
Mitogens and the Cell Cycle
Intracellular Signaling Affects Focal Adhesions
Some...

